Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fasanmade

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Indian Journal of Endocrinology and Metabolism|July 28, 2012
Profile of Nigerians with diabetes mellitus - Diabcare Nigeria study group (2008): Results of a multicenter studyAndrew E Uloko, Esther N Ofoegbu, Sunday Chinenye, et al.
Nigerian Journal of Clinical Practice|June 18, 2013
Urinary free cortisol in the diagnosis of Cushing's syndrome: how useful?I A Odeniyi, A O Ifedayo, O A Fasanmade, et al.
Nigerian Quarterly Journal of Hospital Medicine|March 7, 2008
Lipid peroxidation and erythrocyte fragility in poorly controlled type 2 diabetes mellitusA A Osuntokl, O A Fasanmade, A O Adekola, et al.
Nigerian Journal of Clinical Practice|February 11, 2015
Body mass index and its effect on serum cortisol levelI A Odeniyi, O A Fasanmade, A O Ogbera, et al.
Clinical Therapeutics|July 12, 2011
Pharmacokinetic properties of infliximab in children and adults with Crohn's disease: a retrospective analysis of data from 2 phase III clinical trialsAdedigbo A Fasanmade, Omoniyi J Adedokun, Marion Blank, et al.
West African Journal of Medicine|April 30, 2023
Outcome of Patients with Common Endocrine Diseases Who Had COVID-19 in two Centers in Lagos, Nigeria: A Cross-Sectional StudyO Oluwole, W Fashola, O B Olopade, et al.
International Journal of Oral and Maxillofacial Surgery|July 5, 2018
Complete spontaneous regression of a metastatic melanoma of the mandible: a case report and follow-up recommendationsJ Schlabe, K A Shah, F Sheerin, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 28, 2010
Serum albumin concentration: a predictive factor of infliximab pharmacokinetics and clinical response in patients with ulcerative colitisA A Fasanmade, O J Adedokun, A Olson, et al.
West African Journal of Medicine|April 6, 2011
Relationship between duration of diagnosis and neuromusculoskeletal complications of middle-aged type 2 diabetes patientsA F Adeniyi, A O Sanya, A A Fasanmade, et al.
Circulation|June 11, 2003
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trialEugene S Chung, Milton Packer, Kim Hung Lo, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Indian Journal of Endocrinology and Metabolism|July 28, 2012
Profile of Nigerians with diabetes mellitus - Diabcare Nigeria study group (2008): Results of a multicenter studyAndrew E Uloko, Esther N Ofoegbu, Sunday Chinenye, et al.
Nigerian Journal of Clinical Practice|June 18, 2013
Urinary free cortisol in the diagnosis of Cushing's syndrome: how useful?I A Odeniyi, A O Ifedayo, O A Fasanmade, et al.
Nigerian Quarterly Journal of Hospital Medicine|March 7, 2008
Lipid peroxidation and erythrocyte fragility in poorly controlled type 2 diabetes mellitusA A Osuntokl, O A Fasanmade, A O Adekola, et al.
Nigerian Journal of Clinical Practice|February 11, 2015
Body mass index and its effect on serum cortisol levelI A Odeniyi, O A Fasanmade, A O Ogbera, et al.
Clinical Therapeutics|July 12, 2011
Pharmacokinetic properties of infliximab in children and adults with Crohn's disease: a retrospective analysis of data from 2 phase III clinical trialsAdedigbo A Fasanmade, Omoniyi J Adedokun, Marion Blank, et al.
West African Journal of Medicine|April 30, 2023
Outcome of Patients with Common Endocrine Diseases Who Had COVID-19 in two Centers in Lagos, Nigeria: A Cross-Sectional StudyO Oluwole, W Fashola, O B Olopade, et al.
International Journal of Oral and Maxillofacial Surgery|July 5, 2018
Complete spontaneous regression of a metastatic melanoma of the mandible: a case report and follow-up recommendationsJ Schlabe, K A Shah, F Sheerin, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 28, 2010
Serum albumin concentration: a predictive factor of infliximab pharmacokinetics and clinical response in patients with ulcerative colitisA A Fasanmade, O J Adedokun, A Olson, et al.
West African Journal of Medicine|April 6, 2011
Relationship between duration of diagnosis and neuromusculoskeletal complications of middle-aged type 2 diabetes patientsA F Adeniyi, A O Sanya, A A Fasanmade, et al.
Circulation|June 11, 2003
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trialEugene S Chung, Milton Packer, Kim Hung Lo, et al.
Pageof 10